insights_auto
Why is EMCURE up ४.५७%?
Dive Deeperchevron_right
EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹ २,३३४.४०
arrow_upward
+४.५७%(+१०२.००) 1D
नोभेम्बर १२, १५:३०:०२ GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹ २,२६०.००
High
₹ २,३४४.४०
Low
₹ २,२४३.६०
Mkt. cap
४.४३ खरब
Avg. vol.
१.९८ लाख
Volume
९.६५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.००
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
Open
₹ २,२६०.००
High
₹ २,३४४.४०
Low
₹ २,२४३.६०
Mkt. cap
४.४३ खरब
Avg. vol.
१.९८ लाख
Volume
९.६५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.००
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
News stories
From web sources and news partners
Eurasia Business News
·
३ घण्टा पहिले
Stock Market Today, November 12, 2026: Dow, S&P 500 and Nasdaq Fall After Jensen Huang Resigns
Investing.com
·
५ घण्टा पहिले
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.36%
ChartMill
·
७ घण्टा पहिले
Most Active S&P 500 Stocks: KDP, Ford, AT&T Lead Today's Session
Traders Union
·
४ घण्टा पहिले
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees६.९१ हजार
Founded१९८१ अप्रिल १६
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com